Genital antibody response to a parenteral gonococcal pilus vaccine.
AUTOR(ES)
McChesney, D
RESUMO
A parenteral gonococcal pilus vaccine which has previously been shown to be safe and antigenic also results in the production of specific local genital antibody. All three major antibody classes were present in the local secretions, but immunoglobulin A predominated, a portion of which is dimeric 11S immunoglobulin A. This mucosal antibody is also capable of blocking the attachment of gonococci to epithelial cells. The antibody cross-reacted with five heterologous pili in a solid-phase radioimmunoassay. These results are encouraging and suggest that a gonococcal pilus vaccine may be efficacious in preventing gonorrhea.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=551431Documentos Relacionados
- Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment.
- Time to peak serum antibody response to influenza vaccine.
- Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine.
- Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine.
- Impaired mucosal antibody response to cholera toxin in vitamin A-deficient rats immunized with oral cholera vaccine.
